Literature DB >> 18037647

Efficacy of antibiotic prophylactic regimens for the prevention of bacterial endocarditis of oral origin.

I Tomás Carmona1, P Diz Dios, C Scully.   

Abstract

Despite the controversy about the risk of individuals developing bacterial endocarditis of oral origin, numerous Expert Committees in different countries continue to publish prophylactic regimens for the prevention of bacterial endocarditis secondary to dental procedures. In this paper, we analyze the efficacy of antibiotic prophylaxis in the prevention of bacteremia following dental manipulations and in the prevention of bacterial endocarditis (in both animal models and human studies). Antibiotic prophylaxis guidelines remain consensus-based, and there is scientific evidence of the efficacy of amoxicillin in the prevention of bacteremia following dental procedures, although the results reported do not confirm the efficacy of other recommended antibiotics. The majority of studies on experimental models of bacterial endocarditis have verified the efficacy of antibiotics administered after the induction of bacteremia, confirming the efficacy of antibiotic prophylaxis in later stages in the development of bacterial endocarditis. There is no scientific evidence that prophylaxis with penicillin is effective in reducing bacterial endocarditis secondary to dental procedures in patients considered to be "at risk". It has been suggested that there is a high risk of severe allergic reactions secondary to prophylactically administered penicillins, but, in reality, very few cases have been reported in the literature. It has been demonstrated that antibiotic prophylaxis could contribute to the development of bacterial resistance, but only after the administration of several consecutive doses. Future research on bacterial endocarditis prophylactic protocols should involve the re-evaluation of the time and route of administration of antibiotic prophylaxis, and a search for alternative antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037647     DOI: 10.1177/154405910708601203

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  7 in total

1.  Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis.

Authors:  Christian Kühn; Claudia Disqué; Helge Mühl; Peter Orszag; Meike Stiesch; Axel Haverich
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

2.  Can we really do without antibiotic prophylaxis for infective endocarditis?

Authors:  Philip J Whatling; J Daniel Robb; Jonathan Byrne; Olaf Wendler
Journal:  BMJ Case Rep       Date:  2011-08-17

3.  Multiple adhesin proteins on the cell surface of Streptococcus gordonii are involved in adhesion to human fibronectin.

Authors:  Nicholas S Jakubovics; Jane L Brittan; Lindsay C Dutton; Howard F Jenkinson
Journal:  Microbiology (Reading)       Date:  2009-08-06       Impact factor: 2.777

Review 4.  Endodontic management of patients with systemic complications.

Authors:  Kalaiselvam Rajeswari; Deivanayagam Kandaswamy; Soundararajan Karthick
Journal:  J Pharm Bioallied Sci       Date:  2016-10

Review 5.  Oral health implications in total hip and knee arthroplasty patients: A review.

Authors:  Joseph R Young; Annika L Bannon; Afshin A Anoushiravani; Andrew D Posner; Curtis T Adams; Matthew R DiCaprio
Journal:  J Orthop       Date:  2021-02-20

6.  Post-tooth extraction bacteraemia: a randomized clinical trial on the efficacy of chlorhexidine prophylaxis.

Authors:  Mario Barbosa; Isabel Prada-López; Maximiliano Álvarez; Barbas Amaral; Casares-De-Cal María de los Angeles; Inmaculada Tomás
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

7.  Antibiotic prophylaxis for implant placement: a systematic review of effects on reduction of implant failure.

Authors:  Andy Seongju Kim; Nancy Abdelhay; Liran Levin; John D Walters; Monica P Gibson
Journal:  Br Dent J       Date:  2020-06       Impact factor: 2.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.